80 results
Page 3 of 4
424B3
7fncgn mr
11 Jun 14
Prospectus supplement
12:00am
8-K
EX-99.1
zpbwh5vv
28 May 14
BioTime Receives ISO 13485 Certification for Medical Devices
12:00am
8-K
EX-99.1
18c6v
3 Mar 14
BioTime Provides Financing and Product Development Update
12:00am
8-K
EX-99.1
x9h6qty5 vjzz5x1
4 Dec 13
BioTime’s CEO, Dr. Michael West to Moderate Session on Mapping the Cellular Basis of Life at the 2013 World Stem Cell Summit
12:00am
8-K
EX-99.1
m7ybaw
28 Oct 13
Regulation FD Disclosure
12:00am
424B3
dh5zpzyxs5 ud
2 Aug 13
Prospectus supplement
12:00am
8-K
EX-99.1
3z9q seifwc
18 Dec 12
BioTime Reports Isolation of Seven Diverse Cartilage and Bone Cell Types From Human Embryonic Stem Cells
12:00am
8-K
EX-99.1
32os98574yk1
1 Nov 12
BioTime Subsidiary OrthoCyte Corporation Announces the Appointment of Francois Binette as Vice President
12:00am
8-K
EX-99.1
p51ndx9smxnq
28 Sep 12
BioTime Forms BioTime Acquisition Corporation
12:00am
DEFA14A
z39y7 qmsgpbg4rrut
5 Jun 12
Additional proxy soliciting materials
12:00am
8-K
EX-99.1
5hcz2utnkv
29 Nov 11
BioTime, Inc. Appoints Andrew C. von Eschenbach, M.D. to its Board of Directors
12:00am